Interestingly, these mRNAs contained the m6A regulator FMR1 (Edupuganti et al., 2017), which confirmed that in HCC, m6ARlnc can act as a ceRNA by targeting m6A regulators through miRNA. Here, FMR1 is linked to hepatocellular carcinoma.